Global Epigenetics Market
Medical Equipment

Epigenetics Market Valuation Expected To Reach $28.68 Billion By 2029, Growing At A Rate Of 22.5%

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Fast Is The Epigenetics Market Expected to Grow Between 2025 And 2029?

In recent times, we’ve seen a swift growth of the epigenetics market size. The prediction shows a development from $10.65 billion in 2024 to $12.74 billion in 2025, with a compound annual growth rate (CAGR) of 19.6%. Factors contributing to the growth during the historic period include an increase in research funding, growing occurrence of chronic diseases, advancement in personalized medicine, cancer research, and an aging population.

There’s an anticipated significant surge in the epigenetics market in the coming years, with the market size projected to reach $28.68 billion by 2029, growing at a compound annual growth rate (CAGR) of 22.5%. The predicted expansion during this period is linked to factors such as the development of epigenetic drugs, the role of epigenetics in environmental health and precision agriculture, favourable regulatory frameworks, and increased patient awareness and advocacy. Additionally, the period is expected to witness certain trends such as epitranscriptomics, single-cell epigenomics, epigenetic editing, the identification of epigenetic biomarkers, research in aging and longevity, and the interaction between microbiomes and epigenomes.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7070&type=smp

Which Factors and External Forces Are Driving Demand in the Epigenetics Market?

The escalating occurrence of cancer and other illnesses is substantially fuelling the expansion of the epigenetics market. The growing incidence of these diseases heightens the need for epigenetics. For instance, in May 2024, the National Cancer Institute (NCI), a US-based government organization, reported that nearly 20 million new cases of cancer were reported in 2022, leading to approximately 9.7 million deaths from the disease. Estimates suggest that by 2040, the annual rate of new cancer diagnoses will rise to 29.9 million, while cancer-related deaths will hit 15.3 million. Additionally, according to the Centers for Disease Control and Prevention (CDC), around 659,000 individuals in the United States succumb to heart disease annually. The escalating occurrence of cancer and other conditions necessitates the testing and understanding of genetic modifications, which will inevitably boost the utilization and demand for epigenetics. Therefore, the escalating occurrence of cancer and other illnesses is set to propel the epigenetics market in the upcoming years.

Which Segments in the Epigenetics Offer the Most Growth?

The epigeneticsmarket covered in this report is segmented –

1) By Product: Reagents, Enzymes, Instruments, Kits

2) By Technology: DNA Methylation, Histone Methylation, Histone Acetylation, Large Noncoding RNA, MicroRNA Modification, Chromatin Structures

3) By Application: Oncology, Metabolic Diseases, Developmental Biology, Immunology, Cardiovascular Diseases, Other Applications

4) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Other End Users

Subsegments:

1) By Reagents: DNA Methylation Reagents, Histone Modification Reagents, RNA Modifications Reagents, Enzymes

2) By Enzymes: DNA Methyltransferases, Histone Acetyltransferases, Histone Deacetylases, Other Epigenetic Enzymes

3) By Instruments: Sequencers, PCR Machines, Microarray Platforms, Mass Spectrometers

4) By Kits: DNA Methylation Kits, Chromatin Immunoprecipitation (ChIP) Kits, RNA-Seq Kits, Bisulfite Conversion Kits

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=7070&type=smp

What Are the Fastest-Growing Geographies in the #Which Factors and External Forces Are Driving Demand in the Epigenetics Market?# Market?

North America was the largest region in the epigenetics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the epigenetics market during the forecast period. The regions covered in the epigenetics market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Which Cutting-Edge Market Trends Are Expected to Drive theEpigenetics Market’s Growth?

Significant entities within the epigenetics market are channeling their efforts to create cutting-edge solutions such as DNA sequencing methodologies. These methods aim to augment precision medicine, enrich disease comprehension, and better therapeutic results. DNA sequencing techniques are instrumental in identifying the sequence of nucleotides within a DNA molecule, a crucial aspect of in-depth genetic analysis. The insights derived from this process play a critical role in locating genetic variations linked to diseases, thus propelling the advancement of precision medicine. For example, Illumina Inc., a biotech company based in the U.S., rolled out the Illumina Complete Long Read Technology in March 2023. This technology harmonizes the process of long-read and short-read sequencing within a single instrument, greatly boosting versatility in the field of genomics studies. The technology reduces DNA input demands and optimizes the workflow, thus simplifying the preparation of libraries, even for the more intricate samples. The system’s efficacy at accurately calling variants ensures the delivery of trustworthy data vital for thorough genomic analysis.

View the full report here:

https://www.thebusinessresearchcompany.com/report/epigenetics-global-market-report

What Are the Key Elements That Define the Epigenetics Market?

Epigenetics is a change in gene activity transmitted to younger cells without modifying the DNA sequence. Epigenetic processes are natural and necessary for many organisms to work, but unusual occurrences can cause disorders, such as various types of cancer, reproductive illnesses, and cardiovascular illnesses. Epigenetics is used detect a type of cancers earlier.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7070

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model